Hello readers! Welcome to the updated Binaytara Foundation news page. Here, we will be providing updates and highlights from our recent events and global efforts, shed light on important issues, and give shout-outs to our incredible supporters. If you would like to learn more about the foundation or get involved, please visit www.binayfoundation.org. You can also find us on Twitter, Facebook, and LinkedIn. Thanks for visiting!
Skin cancer is the most common type of cancer, with 5.4 million cases of nonmelanoma skin cancers in the US annually. Most of these, 8 out of 10, occur in basal cells, and a smaller fraction is found in squamous cells; both types of cells are found in the epidermis, the top layer of skin. Melanoma, skin cancer in the pigment-producing cells, impacts more than 200,000 people yearly. However, such cancers have very high recovery rates because their treatments harness the body’s immune system.
Dr. David Aboulafia, a medical oncologist at Virginia Mason Franciscan Health and board member of the Binaytara Foundation, visited the Binaytara Foundation Cancer Center (BTFCC) in Janakpur, Nepal in March 2020, right as the COVID-19 pandemic was gaining global traction and Washington state was known as the United States “epicenter.”
On March 16, just around the time Dr. Aboulafia returned from his trip, Washington state imposed strict limitations on social gatherings to contain the spread of the coronavirus. That same day, he wrote the first post on his blog, Covid Cogitations.
“I confess I did not know what a blog…
The Binaytara Foundation (BTF) held the Advances in Gastrointestinal Cancers conference on March 28, 2021, via Zoom video conferencing. This meeting had a turnout of 157 healthcare professionals, which included 97 people from the United States and 60 from other countries, including Argentina, Brazil, Canada, China, Egypt, Germany, India, Mexico, Nepal, Saudi Arabia, South Africa, Spain, Turkey, and the UK.
“I think it was a fantastic event because the topics that were presented gave GI oncologists a, high-level overview of the currently evolving fields,” Dr. Arparna Parikh, a medical oncologist and assistant professor of medicine at Harvard University, shares. …
Head and neck cancers impact 66,000 people in the US annually (4% of all cancers) and 14,600 people die from it, the majority of whom are men. April is head and neck cancer awareness month, and it is important to shed light on key information about preventing and treating this cancer.
“I learned that the treatment of head and neck cancer involves the dual challenge of determining the therapy that offers not only the best oncologic outcome but also the best functional outcome,” Dr. Cristina Rodriguez, a medical oncologist at Seattle Cancer Care Alliance and associate professor of medicine at…
Binaytara Foundation held the San Antonio Breast Cancer Symposium (SABCS) Highlights on February 21, 2021, via Zoom video conferencing. The program saw a large turnout of 112 attendees, which included international participants from Argentina, Egypt, Greece, India, Nepal, the Philippines, Romania, and Turkey.
“Highlights is for providers who were unable to attend the [SABCS] conference. Our goal is to pick out the most clinically relevant pieces and deliver that to physicians to make sure the practice is up-to-date,” Dr. Fengting Yan, a medical-oncologists at Swedish Medical Center and the co-moderator for this event, explains.
Speakers at the conference included Dr…
One of our biggest ongoing projects is the continued development and expansion of our 25-bed cancer center in Janakpurdham, Nepal, which will provide services to more than 20,000 patients from southeast Nepal and the nearby Indian state of Bihar.
“Working at the Binaytara Foundation Cancer Center (BTFCC) was different from working at other hospitals in Janakpurdham,” Dr. Rakesh Sah, chief house officer at BTFCC, shares. “Here I had a chance to learn about the standards of care for the patient; we do not compromise anything on patient care here.”
Binaytara Foundation held its Management of Multiple Myeloma: Clinical Updates from ASH20 conference on March 20th, 2021 through Zoom video conferencing. This meeting drew 40 participants, half of who were physicians, and the other half comprised of registered nurses, pharmacists, researchers, residents, and students. We had global participants from Germany, India, and Spain.
“I think BTF conferences stand out for their ease of engagement, high-quality faculty and presentations, and clinically meaningful information,” Dr. Andrew Cowan, an Associate Professor of Medicine at the University of Washington, medical oncologist at Seattle Cancer Care Alliance, and moderator for this meeting, shares.
Binaytara Foundation held its Molecular Therapeutics in Non-Small Cell Lunger Cancer conference on February 28, 2021, via Zoom video conferencing. The program saw a turnout of 88 attendees, a majority of who came from the United States.
“I believe that the conference was a good review of the many recent developments in non-small cell lung cancer, and we discussed several recent trials which are turning out to be practice-changing,” Dr. Joseph Rosales, a medical-oncologist from Virginia Mason Franciscan Health and the moderator for this event, shares.
Dr. Rosales was involved in creating the curricula for this meeting. The goal of…